You searched for Antibody candidate - Page 49 of 69

In Depth 25 Jul 2024

The future of inflammatory bowel disease treatment: what is on the horizon?

…– Howard University AbbVie’s interest in IBD treatments isn’t waning. Last month, it bought up a preclinical candidate from Chinese biopharma FutureGen Biopharmaceutical for $150 million. The candidate FG-M701 inhibits…

July 25, 2024 - 8 minutesmins - By Roohi Mariam Peter

In Depth 28 Jun 2024

Going nuclear: radiopharmaceuticals funding sees surge in 2024

…Biopharma’s drug candidates including its pan-cancer program targeting fibroblast activation protein-α (FAP-α), and its drug candidate for people with metastatic castration-resistant prostate cancer (mCRPC). The billion-dollar buyouts have become part…

June 28, 2024 - 6 minutesmins - By Roohi Mariam Peter

News and Trends 27 Jan 2023

Onxeo to study prostate cancer drug

French biotech company Onxeo S.A. has given an update on the clinical development program of its first-in-class drug candidate AsiDNA. Onxeo has activated its first U.S. clinical study site, Next…

January 27, 2023 - 4 minutesmins - By Jim Cornall

News and Trends 21 Mar 2019

Celgene and Exscientia Sign the Largest Deal in AI for Drug Discovery

…process of identifying promising small molecule drug candidates. “The goal is to deliver 3 preclinical candidates over 3 years,” Hopkins told me. Artificial intelligence is gaining recognition for its potential…

March 21, 2019 - 2 minutesmins - By Clara Rodríguez Fernández

News and Trends 16 Dec 2016

Young Immuno-Oncology Biotechs attract Funding to Cure Metastasis

…candidate that can block three oncological pathways. Although peptides tend to be unpopular because they usually are less specific than antibodies, their small size also facilitates manufacturing and administration. If…

December 16, 2016 - 3 minutesmins - By Clara Rodríguez Fernández

News and Trends 12 Sep 2017

France Invests €15M in Developing a New Generation of Antibiotics

…the CVI. The need for new antibiotics is pressing, but the number of candidates in the pipeline worldwide is alarmingly scarce. However, Deinove has a plan that might work where…

September 12, 2017 - 3 minutesmins - By Clara Rodríguez Fernández

CA illustration explanatory labiotech T cell solid tumor cover art 1

Cell avidity-tuning ensures safe CAR-T therapy for solid tumors

…to evaluate a panel of CAR candidates for ccRCC cancer. The Harvard-based team demonstrated a key advancement with their newly developed G9 anti-CAIX CAR product, which offers potential enhancements in…

May 14, 2024 - 5 minutesmins - By External Contributor

In Depth 12 Mar 2025

Checkpoint inhibitors in cancer: breakthroughs, setbacks, and what’s next

…and EMB-09 steer ahead As approved drugs continue to be studied in the clinic to expand their approval for other cancers, there are various candidates in the clinic as well….

March 12, 2025 - 10 minutesmins - By Roohi Mariam Peter

In Depth 19 Sep 2024

Mitochondrial disease treatments: is a breakthrough on the horizon?

…a pathway known as the PINK1/Parkin pathway that governs mitochondrial quality control. They bind to an undisclosed, novel target. The lead candidate VNA-318 is a brain-penetrant molecule that will head…

September 19, 2024 - 8 minutesmins - By Roohi Mariam Peter

News and Trends 27 Sep 2022

Angel Pharma announces approval of IND application for clinical trial of mupadolimab

…Pharma, a clinical stage biopharmaceutical company owns the rights to mupadolimab in Greater China. Mupadolimab is a humanized monoclonal antibody directed against CD73. In preclinical studies, it has demonstrated immunomodulatory…

September 27, 2022 - 2 minutesmins - By Liza Laws

News and Trends 25 Sep 2019

German Biotech Will Develop Carbohydrate-Targeting Cancer Treatments

…by the Germany-based Boehringer Ingelheim Venture Fund and the French VC firm Kurma Partners. Tacalyx will use the money to generate a lead candidate antibody for the treatment of solid…

September 25, 2019 - 2 minutesmins - By Jonathan Smith

News and Trends 16 Dec 2015

Ovarian Cancer Kills 50,000 Every Year. Now a French Biotech has Bagged €15M to Fight it.

…the pre-clinical stage – evidently to good effect, now the candidate is ready for human trials. As a first-in-class monoclonal antibody, GM102 (3C23K) targets the Anti-Mullerian Human Receptor II (AMHRII),…

December 16, 2015 - 2 minutesmins - By Dani Bancroft

Knowledge hub

Categories

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Approaches

Therapeutic areas

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

R&D

BD

World biotech leaders

Connect with decision-makers and researchers worldwide for collaborative opportunities

Company

Join Us

Subscribe to our newsletter

Advertise with us

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Search Results for: Antibody candidate

The future of inflammatory bowel disease treatment: what is on the horizon?

Going nuclear: radiopharmaceuticals funding sees surge in 2024

Onxeo to study prostate cancer drug

Celgene and Exscientia Sign the Largest Deal in AI for Drug Discovery

Young Immuno-Oncology Biotechs attract Funding to Cure Metastasis

France Invests €15M in Developing a New Generation of Antibiotics

Cell avidity-tuning ensures safe CAR-T therapy for solid tumors

Checkpoint inhibitors in cancer: breakthroughs, setbacks, and what’s next

Mitochondrial disease treatments: is a breakthrough on the horizon?

Angel Pharma announces approval of IND application for clinical trial of mupadolimab

German Biotech Will Develop Carbohydrate-Targeting Cancer Treatments

Ovarian Cancer Kills 50,000 Every Year. Now a French Biotech has Bagged €15M to Fight it.

Subscribe to our newsletter to get the latest biotech news!

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Subscribe to our newsletter

Get the latest biotech news directly to your inbox!

Newsletter Signup - Footer

Subscribe to our newsletter to get the latest biotech news!